First drug approved for most common inherited kidney disease

First drug approved for most common inherited kidney disease  Washington Post JYNARQUE™ Approved as First Treatment for Polycystic Kidney Disease  Benzinga FDA OKs Tolvaptan, First Treatment to Slow Kidney Function Decline  MD MagazineFull coverage

(CLICK HERE TO READ AND SEE MORE)